The SpaceX Crew-12 mission is reaching its final stage. After months of intense activity aboard the International Space Station (ISS)—the largest modular space station in low Earth orbit—the astronauts are preparing for their return to Earth, scheduled for early October 2026.
The multidisciplinary team consisted of Jessica Meir and Jack Hathaway (USA), Sophie Adenot (France/ESA), and Andrey Fedyaev (Russia/Roscosmos), who transformed the orbital laboratory into a cutting-edge technological hub.
🚀 Innovation in Science & Tech
The mission went beyond simple observation, focusing on the practical application of disruptive technologies:
- Space Manufacturing: Use of a metal 3D printer to manufacture spare parts on demand, significantly reducing the logistics and cost of shipments from Earth.
- Quantum Computing: Operation of the Cold Atom Lab to optimize solar cells and next-generation processors.
- Medical Autonomy: Implementation of an in-situ intravenous fluid generation system.
- Genetics: DNA sequencing of antibiotic-resistant bacteria to improve healthcare in closed environments.
🩺 Medical Breakthroughs
One of the pillars of Crew-12 was advanced biological research. The results obtained could revolutionize terrestrial treatments:
| Study Area | Objective / Application |
|---|---|
| Crystals | Improving cancer therapies. |
| Stem Cells | Treatment for leukemia and blood diseases. |
| Cartilage Tissue | Creation of regenerative medical implants. |
| Wooden Scaffolds | Fighting osteoporosis and bone loss. |
To maintain this level of operationality, the mission relied on the logistical support of the Cygnus XL spacecraft, which supplied everything from fresh food to critical tools for space weather modeling and the study of the intestinal microbiome.
Source: NASA